Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology Average | - - | - - | - - | 13,941.42 | 863.20 | 216.04 | -109.55 | 37.98 | 0.03 | 0.6318 | -0.35 | -115.8726 | -2,525.7309 | -9.50 | -9.04 | 804.3174 | - - | ||
Maximum | - - | - - | - - | 593,737.00 | 65,349.00 | 25,407.00 | 99,050.00 | 5,305.00 | 0.94 | 701.8537 | 6.70 | 300.5100 | 8,534.8500 | 38.40 | 835.37 | 6,156.2100 | - - | ||
Minimum | - - | - - | - - | 0.00 | 0.00 | -1,175.00 | -56,335.00 | -1,185.00 | 0.00 | -164.8536 | -8.99 | -10,177.5800 | -144,478.0000 | -155.91 | -1,263.79 | 0.0700 | - - | ||
TG Therapeutics, Inc. TGTX | 25.28 | 0.03 0.12% | 3,815 vs. 3,227 | 3,913.00 | 63.00 | -10.00 | -8.00 | -1,525.00 | -0.0732 | -50.4229 | 0.00 | 91.30 | -16.87 | -6.69 | -2.87 | 275.64 | 154.00 | ||
Madrigal Pharmaceuticals, Inc. MDGL | 242.25 | 9.09 3.90% | 287 vs. 281 | 5,259.00 | 0.00 | -147.00 | -149.00 | -1,483.00 | -7.3800 | -8.6674 | 0.00 | 0.00 | 0.00 | -17.34 | -13.63 | 926.23 | 21.00 | ||
Sarepta Therapeutics, Inc. SRPT | 127.10 | 2.09 1.67% | 571 vs. 1,433 | 12,121.00 | 413.00 | 36.00 | -284.00 | -4,410.00 | 0.3800 | 83.5325 | 0.00 | 87.77 | 8.74 | 3.76 | 1.12 | 297.37 | 95.00 | ||
PTC Therapeutics, Inc. PTCT | 36.16 | 0.68 1.92% | 507 vs. 687 | 2,781.00 | 210.00 | -91.00 | 6.00 | -3,375.00 | -1.2000 | -5.9705 | 0.00 | 68.46 | -43.58 | 10.24 | -5.12 | 188.54 | 76.00 | ||
Krystal Biotech, Inc. KRYS | 184.48 | 1.74 0.95% | 335 vs. 355 | 5,300.00 | 45.00 | 0.00 | 14.00 | -268.00 | 0.0300 | 1336.3467 | 0.00 | 94.65 | 2.06 | 0.12 | 0.11 | 1228.70 | 28.00 |